MTM Laboratories AG Announces New Pivotal Trial Data Resulting in European Launch of the CINtec(R) Histology Kit with Extended Clinical Claims

HEIDELBERG, Germany--(BUSINESS WIRE)--mtm laboratories, a fully integrated cancer diagnostics company with proprietary products marketed globally, today announced the launch of the CE-labeled CINtec® Histology kit with extended claims in Europe. The clinical claims are deduced from the outcome of a recent pan-European pivotal study involving 15 pathologists from France, Spain, Italy and Germany.

MORE ON THIS TOPIC